A Canadian Phase II Trial of Bicalutamide in Patients Receiving Maintenance Avelumab for Metastatic Urothelial Cancer

Condition:   Metastatic Urothelial Carcinoma Interventions:   Drug: Bicalutamide 150 mg;   Drug: Placebo Sponsors:   CHU de Quebec-Universite Laval;   Cancer Research Society Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials